GSK-3 beta inhibitor suppresses symptom onset and progression of ALS model mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koh, Seong-Ho | - |
dc.contributor.author | yu, Hn-Jeung Yu | - |
dc.contributor.author | Kim, Juhan | - |
dc.contributor.author | Kim, Hyun | - |
dc.date.accessioned | 2023-02-07T00:43:39Z | - |
dc.date.available | 2023-02-07T00:43:39Z | - |
dc.date.created | 2022-12-21 | - |
dc.date.issued | 2006-07 | - |
dc.identifier.issn | 0960-8966 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182318 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | GSK-3 beta inhibitor suppresses symptom onset and progression of ALS model mice | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Koh, Seong-Ho | - |
dc.identifier.wosid | 000239229400065 | - |
dc.identifier.bibliographicCitation | 11th International Congress on Neuromuscular Diseases, pp.S66 | - |
dc.relation.isPartOf | 11th International Congress on Neuromuscular Diseases | - |
dc.relation.isPartOf | NEUROMUSCULAR DISORDERS | - |
dc.citation.title | 11th International Congress on Neuromuscular Diseases | - |
dc.citation.startPage | S66 | - |
dc.citation.endPage | S66 | - |
dc.citation.conferencePlace | UK | - |
dc.citation.conferencePlace | Istanbul, TURKEY | - |
dc.citation.conferenceDate | 2006-07-02 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.